Bacterial biofilms: Development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 4, 2013, Pages

  Kostakioti, Maria ^a,c   Hadjifrangiskou, Maria ^b   Hultgren, Scott J ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MONSANTO COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); EUKARYOTA;

AMIDASE; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL POLYSACCHARIDE; CHELATING AGENT; DRUG DERIVATIVE; ENZYME INHIBITOR; NORSPERMIDINE; SILVER DERIVATIVE; SPERMIDINE;

BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM; BACTERIUM ADHERENCE; BIOFILM; DRUG EFFECT; EQUIPMENT CONTAMINATION; EXTRACELLULAR MATRIX; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

AMIDOHYDROLASES; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL ADHESION; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOFILMS; CHELATING AGENTS; ENZYME INHIBITORS; EQUIPMENT CONTAMINATION; EXTRACELLULAR MATRIX; HUMANS; POLYSACCHARIDES, BACTERIAL; SIGNAL TRANSDUCTION; SILVER COMPOUNDS; SPERMIDINE;

EID: 84878998919     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a010306     Document Type: Article

References (245)

1. Agladze K., Wang X, Romeo T. 2005. Spatial periodicity of Escherichia coli K-12 biofilm microstructure initiates during a reversible, polar attachment phase of development and requires the polysaccharide adhesin PGA. J Bacteriol 187: 8237-8246.
2. Allaker RP. 2010. The use of nanoparticles to control oral biofilm formation. J Dent Res 89: 1175-1186.
3. Anderson G.G., Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. 2003. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301: 105-107.
4. Anderson G.G., Martin SM, Hultgren SJ. 2004. Host subversion by formation of intracellular bacterial communities in the urinary tract. Microbes Infect 6: 1094-1101.
5. Allesen-Holm M, Barken KB, Yang L, Klausen M, Webb JS, Kjelleberg S., Molin S, Givskov M, Tolker-Nielsen T. 2006. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 59: 1114-1128.
6. Anderson G.G., Moreau-Marquis S, Stanton BA, O'Toole GA. 2008. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect Immun 76: 1423-1433.
7. Anderson G.G., Goller CC, Justice S, Hultgren SJ, Seed PC. 2010. Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis. Infect Immun 78: 963-975.
8. Bagge N., Hentzer M, Andersen JB, Ciofu O, Givskov M, Hoiby N. 2004. Dynamics and spatial distribution of βlactamase expression in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 48: 1168-1174.
9. Banin E., Vasil ML, Greenberg EP. 2005. Iron and Pseudomonas aeruginosa biofilm formation. ProcNatl Acad Sci 102: 11076-11081.
10. Barken K.B., Pamp SJ, Yang L, Gjermansen M, Bertrand JJ, Klausen M., Givskov M, Whitchurch CB, Engel JN, Tolker-Nielsen T. 2008. Roles of type IV pili, flagellum-mediated motility and extracellularDNA in the formation of mature multicellular structures in Pseudomonas aeruginosa biofilms. Environ Microbiol 10: 2331-2343.
11. Barraud N., Schleheck D, Klebensberger J, Webb JS, Hassett D.J., Rice SA, Kjelleberg S. 2009. Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J Bacteriol 191: 7333-7342.
12. Bearson B.L., Bearson SM. 2008. The role of the QseC quorum-sensing sensor kinase in colonization and norepinephrine-enhanced motility of Salmonella enterica serovar Typhimurium. Microb Pathog 44: 271-278.
13. Beloin C., Roux A, Ghigo JM. 2008. Escherichia coli biofilms. Curr Top Microbiol Immunol 322: 249-289.
14. Beloin C., Valle J, Latour-Lambert P, Faure P, Kzreminski M, Balestrino D., Haagensen JA, Molin S, Prensier G, Arbeille B., et al. 2004. Global impact of mature biofilm lifestyle on Escherichia coli K-12 gene expression. Mol Microbiol 51: 659-674.
15. Berg V., Das P, Chorell E, Hedenstrom M, Pinkner JS, Hultgren S.J., Almqvist F. 2008. Carboxylic acid isosteres improve the activity of ring-fused 2-pyridones that inhibit pilus biogenesis in E. coli. Bioorg Med Chem Lett 18: 3536-3540.
16. Bhomkar P., Materi W, Semenchenko V, Wishart DS. 2010. Transcriptional response of E. coli upon FimH-mediated fimbrial adhesion. Gene Regul Syst Bio 4: 1-17.
17. Bishop B.L., Duncan MJ, Song J, Li G, Zaas D, Abraham SN. 2007. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med 13: 625-630.
18. Blango M.G., Mulvey MA. 2010. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 54: 1855-1863.
19. Bleyer A.J., Mason L, Russell G, Raad II, Sherertz RJ. 2005. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26: 520-524.
20. Bokranz W., Wang X, Tschape H, Romling U. 2005. Expression of cellulose and curli fimbriae by Escherichia coli isolated from the gastrointestinal tract. J Med Microbiol 54: 1171-1182.
21. Boles B.R., Thoendel M, Singh PK. 2005. Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms. Mol Microbiol 57: 1210-1223.
22. Bookstaver P.B., Williamson JC, Tucker BK, Raad II, Sherertz RJ. 2009. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann Pharmacother 43: 210-219.
23. Borlee B.R., Goldman AD, Murakami K, Samudrala R, Wozniak D.J., Parsek MR. 2010. Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix. Mol Microbiol 75: 827-842.
24. Bouckaert J., Berglund J, Schembri M, De Genst E, Cools L, Wuhrer M., Hung CS, Pinkner J, Slattegard R, Zavialov A, et al. 2005. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol 55: 441-455.
25. Boyd A., Chakrabarty AM. 1994. Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl Environ Microbiol 60: 2355-2359.
26. Bragg P.D., Rainnie DJ. 1974. The effect of silver ions on the respiratory chain of Escherichia coli. Can J Microbiol 20: 883-889.
27. Branda S.S., Chu F, Kearns DB, Losick R, Kolter R. 2006. A major protein component of the Bacillus subtilis biofilm matrix. Mol Microbiol 59: 1229-1238.
28. Burrowes B., Harper DR, Anderson J, McConville M, Enright MC. 2011. Bacteriophage therapy: Potential uses in the control of antibiotic-resistant pathogens. Expert Rev Anti Infect Ther 9: 775-785.
29. Burton E., Gawande PV, Yakandawala N, LoVetri K, Zhanel G.G., Romeo T, Friesen AD, Madhyastha S. 2006. Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens. Antimicrob Agents Chemother 50: 1835-1840.
30. Cava F., Lam H, de Pedro MA, Waldor MK. 2010. Emerging knowledge of regulatory roles of D-amino acids in bacteria. Cell Mol Life Sci 68: 817-831.
31. Cegelski L., Marshall GR, Eldridge GR, Hultgren SJ. 2008. The biology and future prospects of antivirulence therapies. Nat Rev Microbiol 6: 17-27.
32. Cegelski L., Pinkner JS, Hammer ND, Cusumano CK, Hung C.S., Chorell E, Aberg V, Walker JN, Seed PC, Almqvist F., et al. 2009. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol 5: 913-919.
33. Cerca N., Jefferson KK, Oliveira R, Pier GB, Azeredo J. 2006. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun 74: 4849-4855.
34. Cerca N., Maira-Litran T, Jefferson KK, Grout M, Goldmann DA, Pier GB. 2007. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide. Proc Natl Acad Sci 104: 7528-7533.
35. Chatzinikolaou I., Zipf TF, Hanna H, Umphrey J, Roberts W.M., Sherertz R, Hachem R, Raad I. 2003. Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 36: 116-119.
36. Chen X., Schluesener HJ. 2008. Nanosilver: A nanoproduct in medical application. Toxicol Lett 176: 1-12.
37. Chen S.L., Hung CS, Xu J, Reigstad CS, Magrini V, Sabo A, Blasiar D., Bieri T, Meyer RR, Ozersky P, et al. 2006. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: A comparative genomics approach. Proc Natl Acad Sci 103: 5977-5982.
38. Chen S.L., Hung CS, Pinkner JS, Walker JN, Cusumano CK, Li Z., Bouckaert J, Gordon JI, Hultgren SJ. 2009. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc Natl Acad Sci 106: 22439-22444.
39. Chorell E., Pinkner JS, Phan G, Edvinsson S, Buelens F, Remaut H., Waksman G, Hultgren SJ, Almqvist F. 2010. Design and synthesis of C-2 substituted thiazolo and dihydrothiazolo ring-fused 2-pyridones: Pilicides with increased antivirulence activity. J Med Chem 53: 5690-5695.
40. Chorell E., Bengtsson C, Sainte-Luce Banchelin T, Das P, Uvell H., Sinha AK, Pinkner JS, Hultgren SJ, Almqvist F. 2011. Synthesis and application of a bromomethyl substituted scaffold to be used for efficient optimization of anti-virulence activity. Eur J Med Chem 46: 1103-1116.
41. Clarke M.B., Hughes DT, Zhu C, Boedeker EC, Sperandio V. 2006. The QseC sensor kinase: A bacterial adrenergic receptor. Proc Natl Acad Sci 103: 10420-10425.
42. Connell I., Agace W, Klemm P, Schembri M, Marild S, Svanborg C. 1996. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci 93: 9827-9832.
43. Conrad A., Suutari MK, Keinanen MM, Cadoret A, Faure P, Mansuy-Huault L, Block JC. 2003. Fatty acids of lipid fractions in extracellular polymeric substances of activated sludge flocs. Lipids 38: 1093-1105.
44. Cookson A.L., Cooley WA, Woodward MJ. 2002. The role of type 1 and curli fimbriae of Shiga toxin-producing Escherichia coli in adherence to abiotic surfaces. Int J Med Microbiol 292: 195-205.
45. Costerton J.W., Montanaro L, Arciola CR. 2007. Bacterial communications in implant infections: A target for an intelligence war. Int J Artif Organs 30: 757-763.
46. Cusumano C.K., Pinkner J, Han Z, Greene SE, Ford B, Crowley J.R., Henderson JP, Janetka JW, Hultgren S. 2011. Treatment and prevention of UTI with orally active mannoside FimH inhibitors. Sci Transl Med 3: 109ra115.
47. Danese P.N., Pratt LA, Dove SL, Kolter R. 2000a. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol Microbiol 37: 424-432.
48. Danese P.N., Pratt LA, Kolter R. 2000b. Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J Bacteriol 182: 3593-3596.
49. Dethlefsen L., Relman DA. 2010. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci 108 (Suppl 1): 4554-4561.
50. Dethlefsen L., Huse S, Sogin ML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6: e280.
51. Diggle S.P., Stacey RE, Dodd C, Camara M, Williams P, Winzer K. 2006. The galactophilic lectin, LecA, contributes to biofilm development in Pseudomonas aeruginosa. Environ Microbiol 8: 1095-1104.
52. Domka J., Lee J, Bansal T, Wood TK. 2007. Temporal geneexpression in Escherichia coli K-12 biofilms. Environ Microbiol 9: 332-346.
53. Dong Y.H., Zhang XF, An SW, Xu JL, Zhang LH. 2008. A novel two-component system BqsS-BqsR modulates quorum sensing-dependent biofilm decay in Pseudomonas aeruginosa. Commun Integr Biol 1: 88-96.
54. Donlan RM. 2002. Biofilms: Microbial life on surfaces. Emerg Infect Dis 8: 881-890.
55. Donlan RM. 2009. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17: 66-72.
56. Donlan RM. 2011. Biofilm elimination on intravascular catheters: Important considerations for the infectious disease practitioner. Clin Infect Dis 52: 1038-1045.
57. Dunne WM Jr. 2002. Bacterial adhesion: Seen any good biofilms lately? Clin Microbiol Rev 15: 155-166.
58. Eto D.S., Jones TA, Sundsbak JL, Mulvey MA. 2007. Integrinmediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 3: e100.
59. Fader R.C., Davis CP. 1980. Effect of piliation on Klebsiella pneumoniae infection in rat bladders. Infect Immun 30: 554-561.
60. Feely T., Copley A, Bleyer AJ. 2007. Catheter lock solutions to prevent bloodstream infections in high-risk hemodialysis patients. Am J Nephrol 27: 24-29.
61. Feng Q.L., Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. 2000. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52: 662-668.
62. Ferrieres L., HancockV, Klemm P. 2007. Specific selection for virulent urinary tract infectious Escherichia coli strains during catheter-associated biofilm formation. FEMS Immunol Med Microbiol 51: 212-219.
63. Fey PD. 2010. Modality of bacterial growth presents unique targets: How do we treat biofilm-mediated infections? Curr Opin Microbiol 13: 610-615.
64. Flemming H.C., Wingender J. 2010. The biofilm matrix. Nat Rev Microbiol 8: 623-633.
65. Foxman B. 2010. The epidemiology of urinary tract infection. Nat Rev Urol 7: 653-660.
66. Friedman L., Kolter R. 2004a. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol Microbiol 51: 675-690.
67. Friedman L., Kolter R. 2004b. Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix. J Bacteriol 186: 4457-4465.
68. Garcia-Medina R, Dunne WM, Singh PK, Brody SL. 2005. Pseudomonas aeruginosa acquires biofilm-like properties within airway epithelial cells. Infect Immun 73: 8298-8305.
69. Garofalo C.K., Hooton TM, Martin SM, Stamm WE, Palermo JJ, Gordon JI, Hultgren SJ. 2007. Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect Immun 75: 52-60.
70. Gjermansen M., Ragas P, Sternberg C, Molin S, Tolker-Nielsen T. 2005. Characterization of starvation-induced dispersion in Pseudomonas putida biofilms. Environ Microbiol 7: 894-906.
71. Gotoh Y., Eguchi Y, Watanabe T, Okamoto S, Doi A, Utsumi R. 2010. Two-component signal transduction as potential drug targets in pathogenic bacteria. Curr Opin Microbiol 13: 232-239.
72. Govan J.R., Deretic V. 1996. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539-574.
73. Guiton P.S., Hung CS, Kline KA, Roth R, Kau AL, Hayes E, Heuser J., Dodson KW, Caparon MG, Hultgren SJ. 2009. Contribution of autolysin and Sortase A during Enterococcus faecalis DNA-dependent biofilm development. Infect Immun 77: 3626-3638.
74. Hadjifrangiskou M., Kostakioti M, Chen SL, Henderson JP, Greene S.E., Hultgren SJ. 2011. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol 80: 1516-1529.
75. Hadjifrangiskou M., Gu AP, Pinkner JS, Kostakioti M, Zhang E.W., Greene SE, Hultgren SJ. 2012. Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors. J Bacteriol 194: 6195-6205.
76. Hammer B.K., Bassler BL. 2003. Quorum sensing controls biofilm formation in Vibrio cholerae. Mol Microbiol 50: 101-104.
77. Han Z., Pinkner JS, Ford B, Obermann R, Nolan W, Wildman S.A., Hobbs D, Ellenberger T, Cusumano CK, Hultgren S.J., et al. 2010. Structure-based drug design and optimization of mannoside bacterial FimH antagonists. J Med Chem 53: 4779-4792.
78. Hannan T.J., Mysorekar IU, Hung CS, Isaacson-Schmid ML, Hultgren SJ. 2010. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 6: e1001042.
79. Hansen D.S., Gottschau A, Kolmos HJ. 1998. Epidemiology of Klebsiella bacteraemia: A case control study using Escherichia coli bacteraemia as control. J Hosp Infect 38: 119-132.
80. Harmsen M., Yang L, Pamp SJ, Tolker-Nielsen T. 2010. An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol Med Microbiol 59: 253-268.
81. Hasman H., Chakraborty T, Klemm P. 1999. Antigen-43-mediated autoaggregation of Escherichia coli is blocked by fimbriation. J Bacteriol 181: 4834-4841.
82. Hatch R.A., Schiller NL. 1998. Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob Agents Chemother 42: 974-977.
83. Hay I.D., Remminghorst U, Rehm BH. 2009. MucR, a novel membrane-associated regulator of alginate biosynthesis in Pseudomonas aeruginosa. Appl Environ Microbiol 75: 1110-1120.
84. Henderson I.R., Meehan M, Owen P. 1997. Antigen 43, a phase-variable bipartite outer membrane protein, determines colony morphology and autoaggregation in Escherichia coli K-12. FEMS Microbiol Lett 149: 115-120.
85. Henderson J.P., Crowley JR, Pinkner JS, Walker JN, Tsukayama P., Stamm WE, Hooton TM, Hultgren SJ. 2009. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog 5: e1000305.
86. Hentzer M., Teitzel GM, Balzer GJ, Heydorn A, Molin S, Givskov M., Parsek MR. 2001. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J Bacteriol 183: 5395-5401.
87. Hochbaum A.I., Kolodkin-Gal I, Foulston L, Kolter R, Aizenberg J., Losick R. 2011. Inhibitory effects of D-amino acids on Staphylococcus aureus biofilm development. J Bacteriol 193: 5616-5622.
88. Hoiby N., Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35: 322-332.
89. Hong S.H., Lee J, Wood TK. 2010. Engineering global regulator Hha of Escherichia coli to control biofilm dispersal. Microb Biotechnol 3: 717-728.
90. Horvath DJ Jr, Li B, Casper T, Partida-Sanchez S, Hunstad D.A., Hultgren SJ, Justice SS. 2010. Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Microbes Infect 13: 426-437.
91. Hughes K.A., Sutherland IW, Clark J, Jones MV. 1998a. Bacteriophage and associated polysaccharide depolymerases-Novel tools for study of bacterial biofilms. J Appl Microbiol 85: 583-590.
92. Hughes K.A., Sutherland IW, Jones MV. 1998b. Biofilm susceptibility to bacteriophage attack: The role of phageborne polysaccharide depolymerase. Microbiology 144 (Pt 11): 3039-3047.
93. Hung C.S., Bouckaert J, Hung D, Pinkner J, Widberg C, DeFusco A, Auguste CG, Strouse R, Langermann S, Waksman G., et al. 2002. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol Microbiol 44: 903-915.
94. Inagaki S., Kuramitsu HK, Sharma A. 2005. Contact-dependent regulation of a Tannerella forsythia virulence factor, BspA, in biofilms. FEMS Microbiol Lett 249: 291-296.
95. Izano E.A., Amarante MA, Kher WB, Kaplan JB. 2008. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol 74: 470-476.
96. Jackson K.D., Starkey M, Kremer S, Parsek MR, Wozniak DJ. 2004. Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J Bacteriol 186: 4466-4475.
97. Jacobsen S.M., Stickler DJ, Mobley HL, Shirtliff ME. 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 21: 26-59.
98. Jefferson K.K., GoldmannDA, Pier GB. 2005. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother 49: 2467-2473.
99. Jesaitis A.J., Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard J.B., Duffy JE, Beyenal H, Lewandowski Z. 2003. Compromised host defense on Pseudomonas aeruginosa biofilms: Characterization of neutrophil and biofilm interactions. J Immunol 171: 4329-4339.
100. Justice S.S., Hung C, Theriot JA, Fletcher DA, Anderson GG, Footer M.J., Hultgren SJ. 2004. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci 101: 1333-1338.
101. Justice S.S., Hunstad DA, Seed PC, Hultgren SJ. 2006. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc Natl Acad Sci 103: 19884-19889.
102. Justice S.S., Hunstad DA, Cegelski L, Hultgren SJ. 2008. Morphological plasticity as a bacterial survival strategy. Nat Rev Microbiol 6: 162-168.
103. Kai-Larsen Y, Luthje P, Chromek M, Peters V, Wang X, Holm A., Kadas L, Hedlund KO, Johansson J, Chapman MR, et al. 2010. Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog 6: e1001010.
104. Kalishwaralal K., BarathManiKanth S, Pandian SR, Deepak V, Gurunathan S. 2010. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces 79: 340-344.
105. Kaplan JB. 2010. Biofilm dispersal: Mechanisms, clinical implications, and potential therapeutic uses. J Dent Res 89: 205-218.
106. Karatan E., Watnick P. 2009. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev 73: 310-347.
107. Kau A.L., Hunstad DA, Hultgren SJ. 2005. Interaction of uropathogenic Escherichia coli with host uroepithelium. Curr Opin Microbiol 8: 54-59.
108. Kemp K.D., Singh KV, Nallapareddy SR, Murray BE. 2007. Relative contributions of Enterococcus faecalis OG1RF sortase-encoding genes, srtA and bps (srtC), to biofilm formation and a murine model of urinary tract infection. Infect Immun 75: 5399-5404.
109. Khajanchi B.K., Kozlova EV, Sha J, Popov VL, Chopra AK. 2011. Two-component QseBC signaling system regulates in vitro and in vivo virulence of Aeromonas hydrophila. Microbiology 158: 259-271.
110. Kharidia R., Liang JF. 2011. The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms. J Microbiol 49: 663-668.
111. Kim J.S., Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park Y.K., Park YH, Hwang CY, et al. 2007. Antimicrobial effects of silver nanoparticles. Nanomedicine 3: 95-101.
112. Kite P., Eastwood K, Sugden S, Percival SL. 2004. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 42: 3073-3076.
113. Kjaergaard K., Schembri MA, Ramos C, Molin S, Klemm P. 2000. Antigen 43 facilitates formation of multispecies biofilms. Environ Microbiol 2: 695-702.
114. Klausen M., Aaes-Jorgensen A, Molin S, Tolker-Nielsen T. 2003a. Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol Microbiol 50: 61-68.
115. Klausen M., Heydorn A, Ragas P, Lambertsen L, Aaes-Jorgensen A., Molin S, Tolker-Nielsen T. 2003b. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol 48: 1511-1524.
116. Klebensberger J., Birkenmaier A, Geffers R, Kjelleberg S, Philipp B. 2009. SiaA and SiaD are essential for inducing autoaggregation as a specific response to detergent stress in Pseudomonas aeruginosa. Environ Microbiol 11: 3073-3086.
117. Klein T., Abgottspon D, Wittwer M, Rabbani S, Herold J, Jiang X., Kleeb S, Luthi C, Scharenberg M, Bezencon J, et al. 2010. FimH antagonists for the oral treatment of urinary tract infections: From design and synthesis to in vitro and in vivo evaluation. J Med Chem 53: 8627-8641.
118. Kline K.A., Dodson KW, Caparon MG, Hultgren SJ. 2010. A tale of two pili: Assembly and function of pili in bacteria. Trends Microbiol 18: 224-232.
119. Koch C., Hoiby N. 1993. Pathogenesis of cystic fibrosis. Lancet 341: 1065-1069.
120. Kolodkin-Gal I, Romero D, Cao S, Clardy J, Kolter R, Losick R. 2010. D-amino acids trigger biofilm disassembly. Science 328: 627-629.
121. Kolodkin-Gal I, Cao S, Chai L, Bottcher T, Kolter R, Clardy J, Losick R. 2012. A self-produced trigger for biofilm disassembly that targets exopolysaccharide. Cell 149: 684-692.
122. Koo H., Xiao J, Klein MI, Jeon JG. 2010. Exopolysaccharides produced by Streptococcus mutans glucosyltransferases modulate the establishment of microcolonies within multispecies biofilms. J Bacteriol 192: 3024-3032.
123. Kostakioti M., Hadjifrangiskou M, Pinkner JS, Hultgren SJ. 2009. QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli. Mol Microbiol 73: 1020-1031.
124. Kuramitsu H.K., Wang BY. 2011. The whole is greater than the sum of its parts: Dental plaque bacterial interactions can affect the virulence properties of cariogenic Streptococcus mutans. Am J Dent 24: 153-154.
125. Lam H., Oh DC, Cava F, Takacs CN, Clardy J, de Pedro MA, Waldor MK. 2009. D-amino acids govern stationary phase cell wall remodeling in bacteria. Science 325: 1552-1555.
126. Leid J.G., Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. 2005. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-γmediated macrophage killing. J Immunol 175: 7512-7518.
127. Lemon K.P., Higgins DE, Kolter R. 2007. Flagellar motility is critical for Listeria monocytogenes biofilm formation. J Bacteriol 189: 4418-4424.
128. Lenz A.P., Williamson KS, Pitts B, Stewart PS, Franklin MJ. 2008. Localized gene expression in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 74: 4463-4471.
129. Lewis K. 2005. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 70: 267-274.
130. Lewis K. 2008. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 322: 107-131.
131. Lu T.K., Collins JJ. 2007. Dispersing biofilms with engineered enzymatic bacteriophage. ProcNatl Acad Sci 104: 11197-11202.
132. Lye W.C., Chan RK, Lee EJ, Kumarasinghe G. 1992. Urinary tract infections in patients with diabetes mellitus. J Infect 24: 169-174.
133. Lyon G.J., Mayville P, Muir TW, Novick RP. 2000. Rational design of a global inhibitor of the virulence response in Staphylococcus aureus, based in part on localization of the site of inhibition to the receptor-histidine kinase, AgrC. Proc Natl Acad Sci 97: 13330-13335.
134. Ma L., Jackson KD, Landry RM, Parsek MR, Wozniak DJ. 2006. Analysis of Pseudomonas aeruginosa conditional psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment. J Bacteriol 188: 8213-8221.
135. Ma L., Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ. 2009. Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 5: e1000354.
136. Ma Q., Guishan Z, Wood TK. 2011a. Escherichia coli BdcA controls biofilm dispersal in Pseudomonas aeruginosa and Rhizobium meliloti. BMC Res Notes 4: 447.
137. MaQ, Yang Z, Pu M, PetiW, Wood TK. 2011b. Engineering a novel c-di-GMP-binding protein for biofilm dispersal. Environ Microbiol 13: 631-642.
138. Mack D., Becker P, Chatterjee I, Dobinsky S, Knobloch JK, Peters G., Rohde H, Herrmann M. 2004. Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: Functional molecules, regulatory circuits, and adaptive responses. Int J Med Microbiol 294: 203-212.
139. Mai-Prochnow A, Lucas-Elio P, Egan S, Thomas T, Webb JS, Sanchez-Amat A, Kjelleberg S. 2008. Hydrogen peroxide linked to lysine oxidase activity facilitates biofilm differentiation and dispersal in several gram-negative bacteria. J Bacteriol 190: 5493-5501.
140. Mann E.E., Rice KC, Boles BR, Endres JL, Ranjit D, Chandramohan L, Tsang LH, Smeltzer MS, Horswill AR, Bayles KW. 2009. Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS ONE 4: e5822.
141. Martinez J.J., Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ. 2000. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. Embo J 19: 2803-2812.
142. Matsukawa M., Greenberg EP. 2004. Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development. J Bacteriol 186: 4449-4456.
143. Mohamed J.A., Huang W, Nallapareddy SR, Teng F, Murray BE. 2004. Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect Immun 72: 3658-3663.
144. Mohamed J.A., Teng F, Nallapareddy SR, Murray BE. 2006. Pleiotrophic effects of 2 Enterococcus faecalis sagA-like genes, salA and salB, which encode proteins that are antigenic during human infection, on biofilm formation and binding to collagen type I and fibronectin. J Infect Dis 193: 231-240.
145. Monds R.D., O'Toole GA. 2009. The developmental model of microbial biofilms: Ten years of a paradigm up for review. Trends Microbiol 17: 73-87.
146. Morgan R., Kohn S, Hwang SH, Hassett DJ, Sauer K. 2006. BdlA, a chemotaxis regulator essential for biofilm dispersion in Pseudomonas aeruginosa. J Bacteriol 188: 7335-7343.
147. Morici L.A., Carterson AJ, Wagner VE, Frisk A, Schurr JR, Honer zu Bentrup K, Hassett DJ, Iglewski BH, Sauer K, Schurr MJ. 2007. Pseudomonas aeruginosa AlgR represses the Rhl quorum-sensing system in a biofilm-specific manner. J Bacteriol 189: 7752-7764.
148. Morones J.R., Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez J.T., Yacaman MJ. 2005. The bactericidal effect of silver nanoparticles. Nanotechnology 16: 2346-2353.
149. Mulvey M.A., Lopez-Boado YS, Wilson CL, Roth R, Parks W.C., Heuser J, Hultgren SJ. 1998. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282: 1494-1497.
150. Nakayama J., Tanaka E, Kariyama R, Nagata K, Nishiguchi K, Mitsuhata R, Uemura Y, Tanokura M, Kumon H, Sonomoto K. 2007. Siamycin attenuates fsr quorum sensing mediated by a gelatinase biosynthesis-activating pheromone in Enterococcus faecalis. J Bacteriol 189: 1358-1365.
151. Nallapareddy S.R., Singh KV, Sillanpaa J, Garsin DA, Hook M., Erlandsen SL, Murray BE. 2006. Endocarditis and biofilm-associated pili of Enterococcus faecalis. J Clin Invest 116: 2799-2807.
152. Nilsson L.M., Yakovenko O, Tchesnokova V, Thomas WE, Schembri M.A., Vogel V, Klemm P, Sokurenko EV. 2007. The cysteine bond in the Escherichia coli FimH adhesin is critical for adhesion under flow conditions. Mol Microbiol 65: 1158-1169.
153. Njoroge J., Sperandio V. 2009. Jamming bacterial communication: New approaches for the treatment of infectious diseases. EMBO Mol Med 1: 201-210.
154. Okada A., Gotoh Y, Watanabe T, Furuta E, Yamamoto K, Utsumi R. 2007. Targeting two-component signal transduction: A novel drug discovery system. Methods Enzymol 422: 386-395.
155. O'Toole GA, Kolter R. 1998. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30: 295-304.
156. O'Toole G, Kaplan HB, Kolter R. 2000. Biofilm formation as microbial development. Annu Rev Microbiol 54: 49-79.
157. Otto K., Silhavy TJ. 2002. Surface sensing and adhesion of Escherichia coli controlled by the Cpx-signaling pathway. Proc Natl Acad Sci 99: 2287-2292.
158. Palchevskiy V., Finkel SE. 2006. Escherichia coli competence gene homologs are essential for competitive fitness and the use of DNA as a nutrient. J Bacteriol 188: 3902-3910.
159. Parsek M.R., Singh PK. 2003. Bacterial biofilms: An emerging link to disease pathogenesis. Annu Rev Microbiol 57: 677-701.
160. Patel R.B., Welling PG. 1980. Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole). Clin Pharmacokinet 5: 405-423.
161. Patrauchan M.A., Sarkisova S, Sauer K, Franklin MJ. 2005. Calcium influences cellular and extracellular product formation during biofilm-associated growth of a marine Pseudoalteromonas sp. Microbiology 151: 2885-2897.
162. Percival S.L., Kite P, Eastwood K, Murga R, Carr J, Arduino M.J., Donlan RM. 2005. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 26: 515-519.
163. Pihl M., Davies JR, Chavez de Paz LE, Svensater G. 2010. Differential effects of Pseudomonas aeruginosa on biofilm formation by different strains of Staphylococcus epidermidis. FEMS Immunol Med Microbiol 59: 439-446.
164. Pinkner J.S., Remaut H, Buelens F, Miller E, Aberg V, Pemberton N., Hedenstrom M, Larsson A, Seed P, Waksman G., et al. 2006. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc Natl Acad Sci 103: 17897-17902.
165. Pompilio A., Scocchi M, Pomponio S, Guida F, Di Primio A, Fiscarelli E., Gennaro R, Di Bonaventura G. 2011. Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. Peptides 32: 1807-1814.
166. Pratt L.A., Kolter R. 1998. Genetic analysis of Escherichia coli biofilm formation: Roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol 30: 285-293.
167. Prigent-Combaret C, Lejeune P. 1999. Monitoring gene expression in biofilms. Methods Enzymol 310: 56-79.
168. Prigent-Combaret C, Brombacher E, Vidal O, Ambert A, Lejeune P., Landini P, Dorel C. 2001. Complex regulatory network controls initial adhesion and biofilm formation in Escherichia coli via regulation of the csgD gene. J Bacteriol 183: 7213-7223.
169. Pruss B.M., Besemann C, Denton A, Wolfe AJ. 2006. A complex transcription network controls the early stages of biofilm development by Escherichia coli. J Bacteriol 188: 3731-3739.
170. Purevdorj-Gage B, Costerton WJ, Stoodley P. 2005. Phenotypic differentiation and seeding dispersal in non-mucoid and mucoid Pseudomonas aeruginosa biofilms. Microbiology 151: 1569-1576.
171. Qin X., Singh KV, Weinstock GM, Murray BE. 2000. Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence. Infect Immun 68: 2579-2586.
172. Qin Z., Ou Y, Yang L, Zhu Y, Tolker-Nielsen T, Molin S, QuD. 2007. Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology 153: 2083-2092.
173. Qin Z., Yang L, Qu D, Molin S, Tolker-Nielsen T. 2009. Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiology 155: 2148-2156.
174. Raad I., Buzaid A, Rhyne J, Hachem R, Darouiche R, Safar H, Albitar M., Sherertz RJ. 1997. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 25: 149-151.
175. Raad I., Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T., Cook G, Costerton W. 2003. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 47: 3580-3585.
176. Raad I.I., Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R. 2008. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 21: 385-392.
177. Rasko D.A., Moreira CG, Li de R, Reading NC, Ritchie JM, Waldor M.K., Williams N, Taussig R, Wei S, Roth M, et al. 2008. Targeting QseC signaling and virulence for antibiotic development. Science 321: 1078-1080.
178. Reigstad C.S., Hultgren SJ, Gordon JI. 2007. Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J Biol Chem 282: 21259-21267.
179. Rendueles O., Kaplan JB, Ghigo JM. 2012. Antibiofilm polysaccharides. Environ Microbiol doi: 10.1111/j.1462-2920.2012.02810.x.
180. RomlingU. 2002. Molecular biology of cellulose production in bacteria. Res Microbiol 153: 205-212.
181. Rosen D.A., Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ. 2007. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 4: e329.
182. Rosen D.A., Pinkner JS, Jones JM, Walker JN, Clegg S, Hultgren SJ. 2008a. Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect Immun 76: 3337-3345.
183. Rosen D.A., Pinkner JS, Walker JN, Elam JS, Jones JM, Hultgren SJ. 2008b. Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract. Infect Immun 76: 3346-3356.
184. Rowe M.C., Withers HL, Swift S. 2010. Uropathogenic Escherichia coli forms biofilm aggregates under iron restriction that disperse upon the supply of iron. FEMS Microbiol Lett 307: 102-109.
185. Rupp M.E., Lisco SJ, Lipsett PA, Perl TM, Keating K, Civetta J.M., Mermel LA, Lee D, Dellinger EP, Donahoe M, et al. 2005. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: A randomized, controlled trial. Ann Intern Med 143: 570-580.
186. Sauer K., Cullen MC, Rickard AH, Zeef LA, Davies DG, Gilbert P. 2004. Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm. J Bacteriol 186: 7312-7326.
187. Schaeffer A.J., Amundsen SK, Jones JM. 1980. Effect of carbohydrates on adherence of Escherichica coli to human urinary tract epithelial cells. Infect Immun 30: 531-537.
188. Schembri M.A., Kjaergaard K, Klemm P. 2003. Global gene expression in Escherichia coli biofilms. Mol Microbiol 48: 253-267.
189. Schmidt J., Musken M, Becker T, Magnowska Z, Bertinetti D, Moller S., Zimmermann B, Herberg FW, Jansch L, Haussler S. 2011. The Pseudomonas aeruginosa chemotaxis methyltransferase CheR1 impacts on bacterial surface sampling. PLoS ONE 6: e18184.
190. Schwartz D.J., Chen SL, Hultgren SJ, Seed PC. 2011. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection. Infect Immun 79: 4250-4259.
191. Secinti K.D., Ozalp H, Attar A, Sargon MF. 2011. Nanoparticle silver ion coatings inhibit biofilm formation on titanium implants. J Clin Neurosci 18: 391-395.
192. Shak S., Capon DJ, Hellmiss R, Marsters SA, Baker CL. 1990. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci 87: 9188-9192.
193. Shanks R.M., Sargent JL, Martinez RM, Graber ML, O'Toole GA. 2006. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 21: 2247-2255.
194. Snyder J.A., Lloyd AL, Lockatell CV, Johnson DE, Mobley HL. 2006. Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection. Infect Immun 74: 1387-1393.
195. Sokurenko E.V., Courtney HS, Ohman DE, Klemm P, Hasty DL. 1994. FimH family of type 1 fimbrial adhesins: Functional heterogeneity due to minor sequence variations among fimH genes. J Bacteriol 176: 748-755.
196. Sokurenko E.V., Courtney HS, Maslow J, Siitonen A, Hasty DL. 1995. Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J Bacteriol 177: 3680-3686.
197. Sokurenko E.V., Chesnokova V, Dykhuizen DE, Ofek I, Wu X.R., Krogfelt KA, Struve C, Schembri MA, Hasty DL. 1998. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci 95: 8922-8926.
198. Sokurenko E.V., Feldgarden M, Trintchina E, Weissman SJ, Avagyan S., Chattopadhyay S, Johnson JR, Dykhuizen DE. 2004. Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli. Mol Biol Evol 21: 1373-1383.
199. Sperling O., Fuchs A, Lindhorst TK. 2006. Evaluation of the carbohydrate recognition domain of the bacterial adhesin FimH: Design, synthesis and binding properties of mannoside ligands. Org Biomol Chem 4: 3913-3922.
200. Spurbeck R.R., Stapleton AE, Johnson JR, Walk ST, Hooton T.M., Mobley HL. 2011. Fimbrial profiles predict virulence of uropathogenic E. coli strains: Contribution of Ygi and Yad fimbriae. Infect Immun 79: 4753-4763.
201. Stanley N.R., Britton RA, Grossman AD, Lazazzera BA. 2003. Identification of catabolite repression as a physiological regulator of biofilm formation by Bacillus subtilis by use of DNA microarrays. J Bacteriol 185: 1951-1957.
202. Starkey M., Hickman JH, Ma L, Zhang N, De Long S, Hinz A, Palacios S., Manoil C, Kirisits MJ, Starner TD, et al. 2009. Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung. J Bacteriol 191: 3492-3503.
203. Sutherland I.W., Hughes KA, Skillman LC, Tait K. 2004. The interaction of phage and biofilms. FEMS Microbiol Lett 232: 1-6.
204. Thankavel K., Madison B, Ikeda T, Malaviya R, Shah AH, Arumugam P.M., Abraham SN. 1997. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J Clin Invest 100: 1123-1136.
205. Thomas V.C., Thurlow LR, Boyle D, Hancock LE. 2008. Regulation of autolysis-dependent extracellular DNA release by Enterococcus faecalis extracellular proteases influences biofilm development. J Bacteriol 190: 5690-5698.
206. Thomas V.C., Hiromasa Y, Harms N, Thurlow L, Tomich J, Hancock LE. 2009. A fratricidal mechanism is responsible for eDNA release and contributes to biofilm development of Enterococcus faecalis. Mol Microbiol 72: 1022-1036.
207. Thumbikat P., Berry RE, Zhou G, Billips BK, Yaggie RE, Zaichuk T., Sun TT, Schaeffer AJ, Klumpp DJ. 2009. Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog 5: e1000415.
208. Tielker D., Hacker S, Loris R, Strathmann M, Wingender J, Wilhelm S., Rosenau F, Jaeger KE. 2005. Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation. Microbiology 151: 1313-1323.
209. Toledo-Arana A, Valle J, Solano C, Arrizubieta MJ, Cucarella C, Lamata M, Amorena B, Leiva J, Penades JR, Lasa I. 2001. The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol 67: 4538-4545.
210. Ton-That H, Schneewind O. 2003. Assembly of pili on the surface of Corynebacterium diphtheriae. Mol Microbiol 50: 1429-1438.
211. Ton-That H, Marraffini LA, Schneewind O. 2004. Sortases and pilin elements involved in pilus assembly of Corynebacterium diphtheriae. Mol Microbiol 53: 251-261.
212. Toutain C.M., Caizza NC, Zegans ME, O'Toole GA. 2007. Roles for flagellar stators in biofilm formation by Pseudomonas aeruginosa. Res Microbiol 158: 471-477.
213. Ubeda C., Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A., Socci ND, van den Brink MR, Kamboj M, et al. 2010. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120: 4332-4341.
214. Uhlich G.A., Cooke PH, Solomon EB. 2006. Analyses of the red-dry-rough phenotype of an Escherichia coli O157:H7 strain and its role in biofilm formation and resistance to antibacterial agents. Appl Environ Microbiol 72: 2564-2572.
215. Ulett G.C., Valle J, Beloin C, Sherlock O, Ghigo JM, Schembri MA. 2007. Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in longterm persistence in the urinary tract. Infect Immun 75: 3233-3244.
216. Vallet I., Olson JW, Lory S, Lazdunski A, Filloux A. 2001. The chaperone/usher pathways of Pseudomonas aeruginosa: Identification of fimbrial gene clusters (cup) and their involvement in biofilm formation. Proc Natl Acad Sci 98: 6911-6916.
217. Vasseur P., Vallet-Gely I, Soscia C, Genin S, Filloux A. 2005. The pel genes of the Pseudomonas aeruginosa PAK strain are involved at early and late stages of biofilm formation. Microbiology 151: 985-997.
218. Venditti M., Biavasco F, Varaldo PE, Macchiarelli A, De Biase L., Marino B, Serra P. 1993. Catheter-related endocarditis due to glycopeptide-resistant Enterococcus faecalis in a transplanted heart. Clin Infect Dis 17: 524-525.
219. Vidal O., Longin R, Prigent-Combaret C, Dorel C, Hooreman M., Lejeune P. 1998. Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert surfaces: Involvement of a new ompR allele that increases curli expression. J Bacteriol 180: 2442-2449.
220. Vilain S., Pretorius JM, Theron J, Brozel VS. 2009. DNA as an adhesin: Bacillus cereus requires extracellular DNA to form biofilms. Appl Environ Microbiol 75: 2861-2868.
221. Vuong C., Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, Otto M. 2004. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 6: 269-275.
222. Waksman G., Hultgren SJ. 2009. Structural biology of the chaperone-usher pathway of pilus biogenesis. Nat Rev Microbiol 7: 765-774.
223. Walters MC 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 47: 317-323.
224. Wang X., Preston JF 3rd, Romeo T. 2004. The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J Bacteriol 186: 2724-2734.
225. Wang X., Dubey AK, Suzuki K, Baker CS, Babitzke P, Romeo T. 2005. CsrA post-transcriptionally represses pgaABCD, responsible for synthesis of a biofilm polysaccharide adhesin of Escherichia coli. Mol Microbiol 56: 1648-1663.
226. Wang X., Wang Q, Yang M, Xiao J, Liu Q, Wu H, Zhang Y. 2011. QseBC controls flagellar motility, fimbrial hemagglutination and intracellular virulence in fish pathogen Edwardsiella tarda. Fish Shellfish Immunol 30: 944-953.
227. Watanabe T., Okada A, Gotoh Y, Utsumi R. 2008. Inhibitors targeting two-component signal transduction. Adv Exp Med Biol 631: 229-236.
228. Watnick P.I., Kolter R. 1999. Steps in the development of a Vibrio cholerae El Tor biofilm. Mol Microbiol 34: 586-595.
229. Webb J.S., Thompson LS, James S, Charlton T, Tolker-Nielsen T., Koch B, Givskov M, Kjelleberg S. 2003. Cell death in Pseudomonas aeruginosa biofilm development. J Bacteriol 185: 4585-4592.
230. Weissman S.J., Beskhlebnaya V, Chesnokova V, Chattopadhyay S, Stamm WE, Hooton TM, Sokurenko EV. 2007. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin. Infect Immun 75: 3548-3555.
231. Welch R.A., Burland V, Plunkett G 3rd, Redford P, Roesch P, Rasko D., Buckles EL, Liou SR, Boutin A, Hackett J, et al. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci 99: 17020-17024.
232. Wellens A., Garofalo C, Nguyen H, Van Gerven N, Slattegard R, Hernalsteens JP, Wyns L, Oscarson S, De Greve H, Hultgren S., et al. 2008. Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoSONE3: e2040.
233. Whitchurch C.B., Tolker-Nielsen T, Ragas PC, Mattick JS. 2002. Extracellular DNA required for bacterial biofilm formation. Science 295: 1487.
234. Whiteley M., Bangera MG, Bumgarner RE, Parsek MR, Teitzel G.M., Lory S, Greenberg EP. 2001. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413: 860-864.
235. Wood T.K., Hong SH, Ma Q. 2010. Engineering biofilm formation and dispersal. Trends Biotechnol 29: 87-94.
236. Wright K.J., Seed PC, Hultgren SJ. 2007. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol 9: 2230-2241.
237. Wu Y., Outten FW. 2009. IscR controls iron-dependent biofilm formation in Escherichia coli by regulating type I fimbria expression. J Bacteriol 191: 1248-1257.
238. Yamanaka M., Hara K, Kudo J. 2005. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energyfiltering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol 71: 7589-7593.
239. Yang D., Biragyn A, Kwak LW, Oppenheim JJ. 2002. Mammalian defensins in immunity: More than just microbicidal. Trends Immunol 23: 291-296.
240. Yang L., Barken KB, Skindersoe ME, Christensen AB, Givskov M., Tolker-Nielsen T. 2007. Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa. Microbiology 153: 1318-1328.
241. Zhang L., Mah TF. 2008. Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J Bacteriol 190: 4447-4452.
242. Zhou G., Mo WJ, Sebbel P, Min G, Neubert TA, Glockshuber R, Wu XR, Sun TT, Kong XP. 2001. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: Evidence from in vitro FimH binding. J Cell Sci 114: 4095-4103.
243. Zhu Y., Weiss EC, Otto M, Fey PD, Smeltzer MS, Somerville GA. 2007. Staphylococcus aureus biofilm metabolism and the influence of arginine on polysaccharide intercellular adhesin synthesis, biofilm formation, and pathogenesis. Infect Immun 75: 4219-4226.
244. Zogaj X., Nimtz M, Rohde M, BokranzW, Romling U. 2001. The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix. MolMicrobiol 39: 1452-1463.
245. Zogaj X., Bokranz W, Nimtz M, Romling U. 2003. Production of cellulose and curli fimbriae by members of the family Enterobacteriaceae isolated from the human gastrointestinal tract. Infect Immun 71: 4151-4158.